![]() |
|
AUXILIUM is a specialty biopharmaceutical company committed to developing innovations for unmet medical needs like Dupuytrens disease.
Enroll now to get free patient education tools and information about Dupuytrens disease.
Committed to developing a nonsurgical choice for Dupuytrens disease
References: Brenner P, Rayan GM. Ground substance and cells of the extracellular matrix. In: Dupuytrens Disease: A Concept of Surgical Treatment. New York: Springer; 2003:23-36. Hurst LC, Badalamente MA. Histopathology and cell biology. In: Tubiana R, Leclercq C, Hurst L, Badalamente MA, Mackin EJ, eds. Dupuytrens Disease. London: Martin Dunitz Ltd; 2000:59-77. Melling M, Karimian-Teherani D, Mostler S, Behnam M, Sobal G, Menzel EJ. Changes of biochemical and biomechanical properties in Dupuytren disease. Arch Pathol Lab Med. 2000;124:1275-1281.
|
||||||||||
![]() |
|
|||||||||||